5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The China Companion Animal Health Market is segmented by Products and Animal Type (Dogs and Cats, Horses, and Other Companion Animals).
The China companion health market is primarily driven by the rising popularity of pet ownership and growing spending on animal healthcare and rising awareness regarding the various treatments available for companion animal diseases.
In recent years, there has been a significant increase in the adoption of dogs and cats that has been observed in China, as they are the most favourite companions of human beings. According to the National Bureau of Statistics of China, it has been estimated that China is the third-largest country, in terms of dog ownership, a total of 27.4 million pet dogs, standing behind the United States and Brazil, with 55.3 million and 35.7 million dogs, respectively. China also stands second in the ownership of pet cats (58.1 million).The pet industry in China is booming and the growth rates in the region are comparable to the other developed countries. Hence, the increase in pet adoption has helped in driving the companion health market.
With the increase in the number of companion animals, owners are becoming increasingly aware of their pet’s health and nutrition, and are also seeking veterinary services. This, in turn, is creating a growing demand for diversified forms of companion animal healthcare products.
Furthermore, there are also increasing initiatives by the government and animal welfare association for creating awareness about the various disease against companion animals which will augment the growth of the market as awareness can prevent various animal related disease. In addition, The growing investments by key market players to develop advanced solutions for pet care is also one of the key contributors to the growth of the china companion animal health market.
The availability of a considerable number of counterfeit animal products and drugs in the market, including a number of fake or copied companion animal drugs being identified as an obstruction to the growth of the market for genuine animal drug products. These drugs are found to be unsafe and ineffective that are found to be harmful for the health and well-being of pets, and may affect a large section of the pets population. This is likely to hamper the market growth over the forecast period.
Companion animals serve humans by providing them company, as well as by guarding their houses and offices. Nowadays, the various types of health diseases developed in animals have increased the demand for vaccines and diagnostic tests. This surge in the demand is because of the need to treat and cure the variety of diseases associated with the health of cats and dogs.
|By Animal Type|
|Dogs and Cats|
|Other Companion Animals|
Report scope can be customized per your requirements. Click here.
To understand key trends, Download Sample Report
Leading global companies are partnering with the Chinese companies for their distribution in the country. For instance, Meili Omni-Honesty is a joint venture between Boehringer Ingelheim, a leading global pharmaceutical company and the world's second-largest animal health company, Beijing KangMu Omni-Honesty Animal Health Products Co. Ltd.
Key market players in the market include Bayer AG, China Animal Husbandry Co. Ltd, Dachang, Elanco Animal Health, Merck & Co., Vetoquinol SA, Virbac, and Zoetis Inc., among others.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Pet Adoption, Mostly by Nuclear Families
4.2.2 Increasing in Initiatives by the Governments and Animal Welfare Associations
4.2.3 Advanced Technology in Animal Healthcare
4.3 Market Restraints
4.3.1 Use of Counterfeit Medicines
4.3.2 Increasing Costs of Animal Testing and Veterinary Care
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Products
126.96.36.199 Medicinal Feed Additives
188.8.131.52 Other Therapeutics
184.108.40.206 Immunodiagnostic Tests
220.127.116.11 Molecular Diagnostics
18.104.22.168 Diagnostic Imaging
22.214.171.124 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs and Cats
5.2.3 Other Companion Animals
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 China Animal Husbandry Co. Ltd
6.1.4 Elanco Animal Health
6.1.5 Merck & Co.
6.1.6 Vetoquinol SA
6.1.8 Zoetis Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments